Gene silencing of VP1 gene of coxsackievirus B3 neurotropic strain Nancy by dsRNAs and siRNAs

References (in the order of mention)

• Bergelson JM, Krithivas A, Celi L, et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol. 1998;72(1):415–419.
   PubMed Web of Science ®Google Scholar
• Rossmann M, He Y, Kuhn R. Picornavirus-receptor interactions. Trends Microbiol. 2002;10(7):324–331.
   PubMed Web of Science ®Google Scholar
• Oberste MS, Pallansch MA. Coxsackieviruses. In: Mahy BWJ, Van Regenmortel MHV, editors. Encyclopedia of virology. 3rd ed. Atlanta, GA: Academic Press; 2008. p. 580–587. https://doi.org/10.1016/B978-012374410-4.00372-1
   Google Scholar
• Semler BL, Ramsingh A. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004;17(3):358–369.
   Google Scholar
• Huber S, Ramsingh A. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004;17(3):358–369.
   PubMed Web of Science ®Google Scholar
• Melnick J. Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fundamental virology. New York, NY: Raven Press; 1996. p. 655–712.
   Google Scholar
• Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin Fetal Neonatal Med. 2009;14(4):222–227.
   PubMed Web of Science ®Google Scholar
• Romero JR. Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol. 2008;323:223–239.
   PubMed Web of Science ®Google Scholar
• Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21(4):446–457.
   PubMed Web of Science ®Google Scholar
• Euscher E, Davis J, Holzman I, et al. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol. 2001;98(6):1019–1026.
   PubMed Web of Science ®Google Scholar
• Chapman N, Kim K. Persistent coxsackievirus infection: Enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol. 2008;323:275–292.
   PubMed Web of Science ®Google Scholar
• Cree BC, Bernardini GL, Hays AP, et al. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol. 2003;60(1):107–112.
   PubMedGoogle Scholar
• Woodall CJ, Riding MH, Graham DI, et al. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ. 1994;308(6943):1541–1543.
   PubMedGoogle Scholar
• Woodall CJ, Graham DI. Evidence for neuronal localisation of enteroviral sequences in motor neurone disease/amyotrophic lateral sclerosis by in situ hybridization. Eur J Histochem. 2004;48(2):129–134.
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JH, Cho KC, et al. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modifi ed poly(ethylenimine). J. Control Release. 2005;104:223–232.
   PubMed Web of Science ®Google Scholar
• McManus B, Chow L, Wilson J, et al. Direct myocardial injury by enterovirus: a Central role in the evolution of murine myocarditis. Clin Immunol Immunopathol. 1993;68(2):159–169.
   PubMedGoogle Scholar
• Huber S. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest. 1997;76(5):691–701.
   PubMed Web of Science ®Google Scholar
• Haasnoot J, Westerhout EM, Berkhout B. RNA interference against viruses: Strike and counterstrike. Nat Biotechnol. 2007;25(12):1435–1443.
   PubMed Web of Science ®Google Scholar
• Mescalchin A, Restle T. Oligomeric nucleic acids as antivirals. Molecules. 2011;16(2):1271–1296.
   PubMed Web of Science ®Google Scholar
• Schubert S, Rothe D, Werk D, et al. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs. Antiviral Res. 2007;73(3):197–205.
   PubMed Web of Science ®Google Scholar
• Merl S, Michaelis C, Jaschke B, et al. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation. 2005;111(13):1583–1592.
   PubMed Web of Science ®Google Scholar
• Ahn J, Jun ES, Lee HS, et al. A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J Virol. 2005;79(13):8620–8624.
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhang J, Wong B, et al. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin. Cell Death Differ. 2005a;12(8):1097–1106.
   PubMed Web of Science ®Google Scholar
• Werk D, Schubert S, Lindig V, et al. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol Chem. 2005;386(9):857–863.
   PubMed Web of Science ®Google Scholar
• Fechner H, Sipo I, Westermann D, et al. Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. J Mol Med. 2008;86(9):987–997.
   PubMed Web of Science ®Google Scholar
• Sin J, Mangale V, Thienphrapa W, et al. Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology. 2015;484:288–304.
   PubMed Web of Science ®Google Scholar
• Kitamura N, Semler BL, Rothberg PG, et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291(5816):547–553.
   PubMed Web of Science ®Google Scholar
• Gamarnik AV, Andino R. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev. 1998;12(15):2293–2304.
   PubMed Web of Science ®Google Scholar
• Vogt DA, Andino R. An RNA element at the 5’-end of the poliovirus genome functions as a general promoter for RNA synthesis. PLoS Pathog. 2010;6(6):e1000936.
   PubMed Web of Science ®Google Scholar
• Fujita K, Krishnakumar SS, Franco D, et al. Membrane topography of the hydrophobic anchor sequence of poliovirus 3A and 3AB proteins and the functional effect of 3A/3AB membrane association upon RNA replication. Biochemistry. 2007;46(17):5185–5199.
   PubMed Web of Science ®Google Scholar
• Petrov N, Stoyanova M, Galabov A. Inhibition of coxsackievirus B3 cardiotropic strain woodruff replication by silencing essential viral genes. Biotechnol Biotechnol Equip. 2019;33(1):1582–1589.
   Web of Science ®Google Scholar
• Rott ME, Jelkmann W. Characterization and detection of several filamentous viruses of cherry: adaptation of an alternative cloning method (DOP-PCR) and modification of an RNA extraction protocol. Eur J Plant Pathol. 2001;107(4):411–420.
   Web of Science ®Google Scholar
• Woodruff JF. Viral myocarditis. A review. Am J Pathol. 1980;101(2):425–484.
   PubMed Web of Science ®Google Scholar
• Fairweather D, Kaya Z, Shellam GR, et al. From infection to autoimmunity. J Autoimmun. 2001;16(3):175–186.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Li YC, Chen P, et al. MG-132 attenuates cardiac deterioration of viral myocarditis via AMPK pathway. Biomed Pharmacother. 2020;126:110091.
   PubMed Web of Science ®Google Scholar
• Song JH, Ahn JH, Kim SR, et al. Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway. Sci Rep. 2019;9(1):9413.
   PubMedGoogle Scholar
• Wei Y, Wang H, Xi C, et al. Antiviral effects of novel 2-Benzoxyl-Phenylpyridine derivatives. Molecules. 2020;25(6):1409.
   PubMed Web of Science ®Google Scholar
• Yuan J, Cheung PK, Zhang HM, et al. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the Central region of the viral positive strand. J Virol. 2005b;79(4):2151–2159.
   PubMed Web of Science ®Google Scholar
• Petrov N, Galabov A. Small interfering RNAs against human enteroviral infections. Acta Microbil Bulg. 2016;32(2):101–107.
   Google Scholar
• Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 2002;418(6896):430–434.
   PubMed Web of Science ®Google Scholar
• von Eije KJ, Ter Brake O, Berkhout B. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol. 2008;82(6):2895–2903.
   PubMed Web of Science ®Google Scholar
• Boden D, Pusch O, Lee F, et al. Human immunodeficiency virus type 1 escape from RNA interference. J Virol. 2003;77(21):11531–11535.
   PubMed Web of Science ®Google Scholar
• Fechner H, Pinkert S, Wang X, et al. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther. 2007;14(12):960–971.
   PubMed Web of Science ®Google Scholar
• Shi Y, Chen C, Lisewski U, et al. Cardiac deletion of the coxsackievirus-adenovirus receptor abolishes coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol. 2009;53(14):1219–1226.
   PubMed Web of Science ®Google Scholar
• Sharma M, Mishra B, Saikia UN, et al. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor. Indian J Med Res. 2017;146(4):520–527.
   PubMed Web of Science ®Google Scholar
• Coyne CB, Bergelson JM. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev. 2005;57(6):869–882.
   PubMed Web of Science ®Google Scholar
• Freimuth P, Philipson L, Carson SD. The coxsackievirus and adenovirus receptor. Curr Top Microbiol Immunol. 2008;323:67–87.
   PubMed Web of Science ®Google Scholar
• Asher DR, Cerny AM, Weiler SR, et al. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis. 2005;42(2):77–85.
   PubMed Web of Science ®Google Scholar
• Chen JW, Zhou B, Yu QC, et al. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ Res. 2006;98(7):923–930.
   PubMed Web of Science ®Google Scholar
• Lisewski U, Shi Y, Wrackmeyer U, et al. The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J Exp Med. 2008;205(10):2369–2379.
   PubMed Web of Science ®Google Scholar
• Lim BK, Xiong D, Dorner A, et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest. 2008;118(8):2758–2770.
   PubMed Web of Science ®Google Scholar
• Pazirandeh A, Sultana T, Mirza M, et al. Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) gene. PLoS One. 2011;6(6):e20203.
   PubMed Web of Science ®Google Scholar
• Fechner H, Pinkert S, Geisler A, et al. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules. 2011;16(10):8475–8503.
   PubMed Web of Science ®Google Scholar
• Merl S, Wessely R. Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides. 2007;17(1):44–53.
   PubMedGoogle Scholar
• Nygardas M, Vuorinen T, Aalto AP, et al. Inhibition of coxsackievirus B3 and related enteroviruses by antiviral short interfering RNA pools produced using phi6 RNA-dependent RNA polymerase. J Gen Virol. 2009;90(Pt 10):2468–2473.
   PubMedGoogle Scholar
• Schubert S, Grunweller A, Erdmann VA, et al. Local RNA target structure influences siRNA efficacy: Systematic analysis of intentionally designed binding regions. J Mol Biol. 2005;348(4):883–893.
   PubMed Web of Science ®Google Scholar
• Akashi H, Miyagishi M, Yokota T, et al. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol Biosyst. 2005;1(5–6):382–390.
   PubMedGoogle Scholar
• Aigner A. Gene silencing through RNA interference (RNAi) in vivo: Strategies based on the direct application of siRNAs. J Biotechnol. 2006;124(1):12–25.
   PubMed Web of Science ®Google Scholar
• Lee HS, Ahn J, Jee Y, et al. Universal and mutation-resistant anti-enteroviral activity: Potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region. J Gen Virol. 2007;88(Pt 7):2003–2012.
   PubMedGoogle Scholar
• Racchi G, Klingel K, Kandolf R, et al. Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cells. Methods Find Exp Clin Pharmacol. 2009;31(2):63–70.
   PubMedGoogle Scholar